Clinical Trial Update: Docetaxel in Combination With Iressa in Previously Treated Patients With Pancreatic Cancer [Phase 2]

View source ↗

Summary

This update reports the completion of a Phase 2 trial evaluating docetaxel in combination with Iressa (gefitinib) in patients with previously treated metastatic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• DOCETAXEL (DOCETAXEL)
• Iressa (gefitinib)

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Metastatic Pancreatic Carcinoma | Phase 2 | Status: COMPLETED